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Abstract: MicroRNAs are short non-coding RNAs that are evolutionarily conserved and are pivotal
post-transcriptional mediators of gene regulation. Together with transcription factors and epigenetic
regulators, they form a highly interconnected network whose building blocks can be classified
depending on the number of molecular species involved and the type of interactions amongst
them. Depending on their topology, these molecular circuits may carry out specific functions that
years of studies have related to the processing of gene expression noise. In this review, we first
present the different over-represented network motifs involving microRNAs and their specific role
in implementing relevant biological functions, reviewing both theoretical and experimental studies.
We then illustrate the recent advances in synthetic biology, such as the construction of artificially
synthesised circuits, which provide a controlled tool to test experimentally the possible microRNA
regulatory tasks and constitute a starting point for clinical applications.
Keywords: microRNA; network motifs; synthetic circuits
1. Introduction
Life as we see it is the result of the complex regulation of organisms’ gene expression, required to
fulfil vital biological tasks. This complexity is well reflected by the intricate network of interactions
between the thousands of genes constituting genomes. Specifically, these interactions are triggered by
the action of transcription factors (TFs), which are the regulatory molecules carrying out the primary
step of either enhancing or inhibiting their target gene’s transcription. The sum of all transcriptional
regulatory relationships throughout an organism’s genome constitutes its transcription network.
Originally, transcription networks were found to be built up of recurring patterns, called network
motifs [1]. Identical motifs have been observed in different organisms ranging from bacteria to humans,
indicating that they constitute the basic subcomponents of transcription networks [2]. The most
acknowledged small scale motifs involve single or multiple target genes and one or more TFs as
master regulators. Depending on its topology, each type of circuit can carry out defined information
processing functions that allow achieving a specific biological task [3]. For example, positive self-loops
slow down dynamical responses and increase variability, whereas negative auto-regulation is well
known for accelerating responses and decreasing noise [4,5]. Coherent feedforward loops can display
response persistence, while incoherent feedforward loops show a hallmark pulse-like outcome and
speed up response. Single input modules, made up of a single TF regulating multiple genes, can
generate temporal expression programmes [2].
Cells 2019, 8, 1540; doi:10.3390/cells8121540 www.mdpi.com/journal/cells
Cells 2019, 8, 1540 2 of 27
The same motifs were later found in mixed regulatory networks, that is in networks that are not
necessarily limited to transcriptional interactions [6,7], and multiple studies have highlighted the role
of microRNAs (miRNAs) as pivotal players in these circuits [8].
MiRNAs are evolutionarily conserved ∼22 nt long non-coding RNA molecules that act as
post-transcriptional gene regulators. Such regulation is achieved through Watson–Crick base pairing
with the target mRNAs, mainly at their 5′ terminus or inside their 3′-UTR region [9]. The strength of
binding, that is the degree of miRNA–mRNA complementarity, determines whether the target mRNA
will be subject to translational repression or mRNA degradation: partial complementarity inhibits
translation, while near-perfect matching results in its degradation [10,11]. Although a large number of
miRNA genes are dispersed over the genome in intergenic regions, more than half of miRNAs reside
in introns of their host genes [12], and bioinformatic analyses suggest that they are usually oriented
on the same DNA strand of the host [13]. Thus, miRNA biogenesis occurs from both independently
transcribed and intron-embedded primary miRNAs [14].
The minimum requirement for miRNA–mRNA interaction is a binding sequence of six consecutive
nucleotides, often called “miRNA seed” [15]. Such a soft constraint allows an miRNA molecule to
bind potentially hundreds of different genes [10]. Indeed, miRNAs typically act in a combinatorial
fashion: a single gene is often targeted by many different miRNAs, and a single miRNA regulates
multiple genes [16]. So far, over 2500 different mature miRNAs have been observed in humans [11],
and an increasing number of regulatory interactions involving miRNAs is currently being uncovered
both by theoretical prediction methods and experimental validation [17].
The way miRNAs interact with their targets is titrative [18]. From a theoretical point of view,
titration mechanisms are characterised by a threshold effect close to the equimolarity of the different
interacting species, hypersensitivity of the system around the threshold and cross-talk among
targets [19–21]. The latter characteristic, also identified as a competing endogenous RNA (ceRNA)
effect, marks indirect interactions among targets in competition for a common pool of miRNAs [22,23].
These targets may include protein coding messenger RNAs and non-coding RNAs such as long
non-coding RNAs [24,25], pseudogenes [26,27] and circular RNAs [28] that act as natural miRNA
sponges, thus co-regulating each other in an miRNA mediated fashion. Within this context, the notion of
trios comprised of one miRNA, one non-coding RNA sponging the miRNA, and one target messenger
RNA has received increasing attention.
MiRNAs regulate fundamental biological processes, such as embryonic development and synaptic
plasticity [6], and play pivotal roles in disease related contexts including diabetes, viral infection [29]
and tumourigenesis [30,31]. Along with the interaction of miRNAs with TFs in the most diverse
biological contexts, their relationship with epigenetics is being increasingly uncovered [32]. However,
it is still partially unclear why miRNAs are so pervasive and conserved. Although there are examples
of in vivo transgenic models either overexpressing or silencing specific miRNAs that produce
a phenotype [33–36], single miRNAs generally exert weak repressive action on their target genes
and rarely show phenotypic outcomes [37].
Furthermore, the results obtained by analysing multi-omics data obtained by over- or
down-expressing a single miRNA in a given cell-line are not always in line with this idea. For instance,
M’baya-Moutoula and collaborators studied the effects of both enhancement and inhibition of
a metabolic disease related miRNA, miR-223, in a monocyte macrophage cell-line [38]. After the
identification of a great number of candidate regulators and targets of miR-223, the most significantly
affected ones were uncovered to be key metabolites. Thus, miR-223 alone seems to be able to clearly
alter cells’ metabolic profiles, possibly impacting on apoptosis and proliferation. Furthermore, miR-34a,
a notable tumour suppressor, has been identified as a hub in miRNA involving regulatory networks [39].
Specifically, Hart and colleagues [39] investigated its influence on genes regulating the immune system
in three different T-cell-lines. Fourteen miR-34a targets out of 193 candidates were experimentally
confirmed to affect T-cell function. Hence, the authors suggested a crucial role of miR-34a in T-cell
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regulation that could be exploited to modulate immune response in cancer related contexts for
therapeutic purposes.
The identification of therapeutic miRNA targets has been lately addressed by Calsina and
colleagues [40] with a multi-omics data analysis in the context of rare neuroendocrine tumours [40].
Prognostic miRNA markers for two specific types of tumour were searched for by integrating
transcriptome, proteome and miRNome data and by validating predictions in vitro. Among the
group of miRNAs identified as a signature of metastasis and progression, a combination of two of
them displayed the strongest correlation with metastatic risk. Specifically, the miR-21-3p/miR-183-5p
axis by itself appears to have the power to critically affect tumour development. Genes altered in
the same cancer types were also linked to overexpression of the 182/96/183 miRNA cluster and to
knockdown of the DLK1-MEG3 miRNA cluster [41].
In essence, even though the single miRNA–target interaction seldom displays phenotypic
outcomes, a number of works suggest that single miRNAs or families involved in a broader interactome,
where their alteration might give rise to cascade-like consequences, can concretely affect cell state
and function.
The emerging idea is that miRNA mediated regulation could serve to manage the impact of
noise in gene expression [42]. A number of studies have addressed the relationship between miRNA
and noise, and the results suggested that miRNAs could provide precision to protein expression by
buffering noise when needed [37,43] or either exploit stochasticity in biological contexts that take
advantage of gene expression variability, such as differentiation processes [44,45].
In this review, we first focus on the roles of microRNAs in network motifs, which will be
discriminated by their different topologies. We will then address artificially synthesised circuits,
which provide additional insight into the possible regulatory tasks that miRNAs can potentially
accomplish and ways of taking advantage of miRNAs’ functionalities in artificial systems.
2. MicroRNAs in Network Motifs
The interplay between miRNAs and TFs in a mixed regulatory circuit, where transcriptional,
post-transcriptional and epigenomic regulatory interactions are joined together, has been proposed
as a guiding structure for the achievement of genetic tasks. The influence of TFs and epigenetic
regulators on miRNAs and vice versa was initially addressed computationally and also recently
confirmed experimentally, mainly using RNA sequencing (RNA-seq) and CLIP (crosslinking followed
by immunoprecipitation) sequencing (CLIP-seq). Analyses of data from the Encyclopedia of DNA
Elements (ENCODE) showed that miRNA mediated circuits are found in real networks significantly
more often than expected by chance, as reviewed in [17,46].
Along with the identification and experimental validation of over-represented network motifs,
which has been possible thanks to the interplay between bioinformatics and computational
methodologies, as well as high throughput and sophisticated modern technologies, mathematical
modelling has been shown to be a powerful tool in the understanding of motif functionality. In the
models formulated over the past years, the miRNA mediated gene expression regulation is studied
as a dynamical system. More broadly, such modelling has also been used for investigating cell and
tissue functions at both spatial and temporal resolution and used as a prediction tool for drug and
therapy development [11]. As clearly discussed in [11], the key ingredients of the modelling of such
gene regulatory networks are the molecular species that compose the network and their interactions.
Gene expression is currently well understood to be a stochastic process [47]. Given the probabilistic
nature of chemical reactions and the small number of molecules involved, fluctuations in the abundance
of such molecules are relevant. Thus, through stochastic modelling, several works deeply investigated
the properties and biological advantages of such networks in the presence of different sources of
noise [45,48,49].
Specifically, a few miRNA mediated circuits are recurring network motifs in mixed regulatory
circuits (Figures 1 and 2). Tsang and colleagues [6] developed a computational method for analysing
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gene expression data, and the results indicated that two classes of circuits are enriched in the human
genome, namely miRNA mediated feedback and feedforward loops (FFLs). More precisely, miRNAs
appear to be often involved in negative feedback circuits and in both coherent and incoherent FFLs.
Moreover, intronic miRNA mediated self-loops (iMSLs), where an miRNA is encoded within an intron
of one of its targets, are also significantly represented in the human regulatory network [13], suggesting
their potential to implement biologically relevant tasks. In this section, we will discuss the main
properties of the most common miRNA mediated motifs, reviewing both theoretical and experimental
studies. These will include miRNA mediated feedback and feed-forward loops, with double negative
feedback loops and intronic miRNA mediated self-loops as peculiar cases.
2.1. MicroRNA Mediated Feedback Loops
Feedback loops (FLs) are among the over-represented miRNA motifs. An FL is a circuit whose
topology is such that the output of the network influences the state of the input. This way, the output
literally “feeds back” on the input. Positive and negative feedback regulation is intuitively useful.
For instance, a TF can limit its own activity by activating a repressor, whereas a double negative
feedback loop can function as a switch between cell states by producing a binary output [42].
As mentioned, an increasing number of TF-miRNA circuits have been identified as FLs [11].
In these circuits, as shown in Figure 1a, a TF either enhances or suppresses the expression of an miRNA,
which in turn post-transcriptionally suppresses the TF [50]. It has been shown that this kind of circuit
can implement a variety of biological functions, ranging from the conversion of a transient upstream
signal in a long-lasting cellular response [6] to the achievement of bistable gene expression and
buffering of noise, be it due to fluctuating transcription, translation and decay processes (intrinsic noise)
or to external (e.g., environmental) factors (extrinsic noise) [11].
The first mentioned feature, that is the response persistence, has been observed for instance in
human breast cells, where an FL involves the let-7 miRNA [51]. The activation of the tyrosine-kinase Src
triggers NF-κB, a TF known for inducing inflammatory response [52]. NF-κB in turn activates LIN28,
while LIN28 inhibits let-7 [52]. Since the latter represses IL-6, the consequence of a Src activation is a
reduced suppression of IL-6 by the miRNA [52]. IL-6 completes the loop by activating NF-κB; the result
is an FL that maintains the cell state triggered by Src activation also in the absence of the initial input [16].
However, the interaction between let-7 and LIN28 appears to be more complex: it is proposed that
they in turn form a double negative FL [53]; see Figure 1b. Recently, the let-7/LIN28 switch has
been related to non-small cell lung cancer as well: Yin and colleagues showed that dysregulation
of this circuit, which is induced by irradiation or chemotherapeutic drugs, can lead to radio- and
chemo-resistance [54].
As a consequence of their importance in determining phenotypic outcomes, miRNAs appear to
be largely involved in cancer related feedback motifs [55]. A well known example involves the E2F
transcription factor, which is notoriously implicated in the regulation of cancer associated phenotypes.
E2F can be regulated by multiple miRNAs belonging to the miR-17-92 cluster [56]. The cluster is
induced by E2F, while some miRNAs of the cluster inhibit E2F post-transcriptionally, thus forming an
FL (see Figure 1d). Lai and co-workers [11] showed by ODE modelling and stochastic simulation that
the miRNA cluster can either function as an oncogene or tumour suppressor depending on the values
of two key parameters: the growth factor signalling intensity and the inhibition of E2F translation
by the miRNA cluster. Moreover, they showed that introducing noise into external signalling or
into E2F expression, the miRNA cluster functions as a noise buffer, thus conferring robustness to the
network. However, there exist several other regulatory loops involving miRNAs in the E2F family
interactome [57]; thus, the E2F regulation network will require further modelling efforts.
A newly published work by Zargar et al. [58] linked miR-155 to Pdcd4 (programmed cell
death 4) and AP-1 in a net positive feedback loop whose different outcomes can lead either to
tongue cancer progression (miR-155 overexpression) or to apoptosis and regression of tumour size
(miR-155 knockdown); see Figure 1f.




























Figure 1. Schemes of feedback loops (FLs). Lines ending with an arrow indicate activation, whereas
T ending lines indicate repression. Simple straight lines indicate that the interaction can either
be activatory or repressive. (a) On the left, the general FL scheme is represented. On the right,
the two possible configurations of a minimal miRNA mediated FL are reported. Adapted from [2].
(b–f) Experimental examples of miRNA mediated FLs. (b) Toggle switch between LIN28 and the let-7
miRNA involved both in inflammation and non-small cell lung cancer. Adapted from [59]. (c) Double
negative FL between Senseless and miR-9a that regulates Drosophila sense organ specification. Adapted
from [42]. (d) Cancer associated positive FL between the miR-17-92 family and E2F. E2F self-activation
is also represented. Adapted from [60]. (e) Regulatory relationships that control transitions between
epithelial, mesenchymal and amoeboid phenotypes. The network is composed of multiple feedback-like
interactions. Adapted from [61]. (f) Positive feedback loop between miR-155 and AP1 involved in
tongue cancer progression. Adapted from [62]. (g) Toggle switch between miR-9 and Hes1 that controls
timing of neuron differentiation. Adapted from [63].
Along with their protein expression fine tuning and noise buffering properties, it appears that
miRNA mediated FLs can generate oscillatory gene expression under some conditions [64]. In this
type of regulatory pattern, the FL components are alternatively repressed or activated over time [11].
For instance, if a TF slowly activates the transcription of an miRNA, whereas the miRNA rapidly
inhibits the TF by repressing its translation or enhancing its degradation, sustained oscillations
emerge [11]. Xue and coworkers [65] examined another loop involving NF-κB: the indirect negative
FL between miR-21 and NF-κB. This circuit was shown to produce oscillations in NF-κB levels.
On the other hand, the related negative FL formed by miR-146ab and IL-6 contributed by dampening
the oscillations [11].
Oscillatory expression patterns play a fundamental role in the timing of neuron differentiation.
Goodfellow et al. [63] studied the negative FL involving miR-9 and Hes1 (Figure 1g), and they found
out that miR-9, which is regulated by NF-κB [66], controls the oscillatory pattern of Hes1 expression.
Again, the presence of an miRNA sets a threshold on the amount of a TF, Hes1: Hes1-high ES cells
commit to the mesodermal fate, whereas Hes1-low ES cells are induced to differentiate as neuron stem
cells [67]. Another work by Moore and colleagues [68] dealt with the p53 oscillations observed in breast
cancer cells upon DNA damage induction. Their results suggested that this oscillatory behaviour is
the outcome of a network of nested FLs where miRNAs tune the amplitude of oscillations [11].
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The circadian clock represents a fundamental oscillatory gene expression program that adapts cell
activity according to environmental fluctuations, most notably light changes [69]. MiRNA mediated
regulation contributes crucially in controlling and maintaining circadian clocks in animals [70]. More
specifically, multiple experimental studies on Drosophila, mouse and human cells [69,71–73] have found
out that circadian rhythms are governed by several miRNA mediated FLs. Although mathematical
modelling studies concerning these circuits are currently lacking, miRNAs may play important roles
in conferring robustness to circadian rhythms by controlling noise and oscillations, similarly to what
has been observed in other contexts [11].
The issue of how the composition of miRNA pools with a common target influences the target
regulation is still under debate. Furthermore, it raises the question of how the variability of miRNAs’
abundances is achieved [44]. Interestingly, a newly published study [74] addresses the regulation
of miRNA abundance during ageing, suggesting that it is controlled by an miRNA mediated FL.
A global decline in miRNA amount with age has been shown, amongst others, in mice [75]. Inukai and
coworkers [74] investigated the miRNA abundance decline in C. elegans and bioinformatically identified
Alg-1/Argonaute as a regulator of global miRNA biogenesis. Alg-1 is putatively targeted by multiple
miRNAs, yet experimental evidence showed that miR-71 post-transcriptionally represses Alg-1,
establishing an FL that influences global miRNA abundance during ageing and concomitantly increases
mRNA expression variability [74].
Several further works could be brought forward to highlight the role of miRNAs in carrying out
diverse biological functions through FLs. For additional references, see [60,62,76–86].
2.1.1. Double Negative Feedback Loops
The double negative feedback loop (DNFL), also known as toggle switch, is a minimal motif
that allows “all-or-none” outcomes, which makes it a suitable processing system in cell fate
decision [16]. This kind of switch has also been found as a recurrent motif in the epi-miRNA
network [17]. Several examples of miRNAs directly interacting with epigenetic machinery have
been uncovered as reciprocally inhibitory switches [7]. For instance, the miR-29 family was shown to
downregulate de novo DNA methylation by targeting two different methyltransferases. Interestingly,
this miRNA cluster was hypermethylated itself in lung cancer, leading to overexpression of the same
methyltransferases [87]. The involvement of many miRNAs in DNFLs, along with mathematical
modelling and experimental proofs, supports the idea that miRNAs provide stability to alternative
phenotypes in the presence of noise [88].
Since miRNAs play important roles in determining cell fate, their involvement in developmental
contexts has been increasingly highlighted [89,90]. For instance, the Drosophila sense organ specification
is achieved through an miRNA mediated DNFL [91]. Which cell will become part of the sense organ
precursor (SOP) is determined stochastically, as it depends on the fluctuations in the level of the
Senseless TF [42]. The DNFL linking miR-9a and Senseless (Figure 1c) is able to transform this noise
into a switch: miR-9a levels are initially uniform among proneural cells, but as Senseless activity
increases proneural gene expression in the SOP, miR-9a is inhibited, while it still remains high in
the surrounding cells: spatially exclusive miRNA domains are achieved [42]. Thus, the presence of
miR-9a ensures that only if Senseless levels overcome a threshold, cells commit to differentiation [42].
Indeed, the generation of mutant flies with extra sense organs has been observed in cases of miR-9a
loss-of-function [92]. A bistable switch is found also in the development of the C. elegans chemosensory
neurons [42]. These are meant to be asymmetric on the left and right sides of the animal: cells must
adopt one of two alternative phenotypes, ASEL and ASER [93]. Their initial state is unstable, and thus
subject to fluctuations by noisy gene expression: the miR-273 family works together with TFs in
a combination of loops that drives cells either to the left or the right type [42].
A DNFL between MALAT1 and miR-663a has recently been proposed as crucial in colon cancer
cell functions [94], and the cancer associated fibroblast phenotype (CAF) has been shown to be tuned by
miR-145 in a reciprocally inhibitory regulatory motif [95]. Another notable cancer related case is that of
Cells 2019, 8, 1540 7 of 27
two miRNA mediated DNFLs that regulate the switch between epithelial and mesenchymal phenotypes in
metastasis [96]. The epithelial to mesenchymal transition (EMT) provides cells with the ability to migrate,
thus initiating metastasis. The reverse transition (MET) allows colonisation and growth of metastases [96].
The two opposite transitions are controlled respectively by the miR-34/SNAIL and miR-200/ZEB DNFLs,
which have been proposed to function together as a bistable switch [97] (see Figure 1e). Meanwhile,
Lu and colleagues [59] showed that the two DNFLs have separate roles in the switch: ZEB/miR-200 FL
effectively carries out the EMT, whereas the SNAIL/miR-34 loop functions as a noise buffer of external
signals that could lead to aberrant EMT activation.
Model analysis showed the existence of a third hybrid phenotype with both migratory and
adhesion properties that could enable collective cell migration [98]. Experimental observations
are consistent with tristability, suggesting that medium levels of miR-200 and ZEB lead to partial
EMT [11]. Later, Huang and co-workers [61] connected the EMT network with the Rac1/Rhoa circuit
that regulates transitions between the mesenchymal and the amoeboid phenotypes, as shown in
Figure 1e. Model simulations showed that the transitions between individual and collective migration
behaviours are regulated by miR-200 and miR-34: high levels of the miRNAs favour individual
migration, thus likely inhibiting the formation of cancer metastasis [11]. One of the most recent
developments concerning the role of miRNAs in the epithelial-mesenchymal transition has been
pursued by Diepenbruck and colleagues [99]. Among a number of different miRNAs, they identified
miR-1199-5p as a strong regulator of EMT. Furthermore, the results showed that miR-1199-5p acts in
a DNFL with the previously mentioned TF ZEB1, and the behaviour of the circuit seems similar to that
of the miR-200 family [99]. However, since miR-200 and miR-1199-5p only share a few common target
genes, they likely carry out distinct functions during the transition [99].
In order to gain deeper insight into the biological functions of the DNFL, it is convenient to
address the case of an miRNA and a TF mutually inhibiting each other, with upstream signals that can
activate them, as depicted in Figure 3a. The example considered here has been investigated by Fang
and co-workers in the context of the glioblastoma multiform human cancer [100]. SOX2, a gene notably
related to glioblastoma, forms a DNFL with miR-145. If miR-145 transcription is more induced than that
of SOX2, its repressive strength over SOX2 will overcome the opposite inhibitory arm, thus leading to
a state where only the miRNA is expressed and SOX2 is silenced (Figure 3b, miR-145-high expression
levels). On the contrary, if SOX2 transcription is favoured over miR-145 transcription, the system
collapses in the only-SOX2 state, where miR-145 is silenced [100] (Figure 3b, SOX2-high expression
levels). Therefore, the DNFL embodies a simple mechanism that allows achieving bistable expression
of its components.
2.2. MicroRNA Mediated Feed-Forward Loops
The FFL is one of the most represented three node network motifs in transcriptional
networks [1,101]. Given its role in a wide range of biological processes [102–104] and its well
established association with diseases (ranging from cancer [17,105,106] to autoimmune diseases [107]),
it is currently widely studied. Its general scheme is shown in Figure 2a, where the edges between
the nodes represent the interactions between the molecules and may have either an activating or
repressing function. The FFL is composed by a master regulator A that regulates the expression of
a target C through two parallel paths: one direct and the other indirect. Through the latter, A directly
regulates the expression of a second player, B, which in turn regulates C [2].
This type of circuit was firstly discovered in Escherichia coli [108] and then in several other organisms
including yeast [1] and humans [101]. Later, different works showed an over-representation of FFLs
mediated by microRNAs at a genome wide level [11,109–111], highlighting their importance in gene
regulatory networks [112]. Specifically, in the case of mammalian genomes, these circuits play crucial
roles in cell decision making, proliferation, development, and differentiation [6,102–104,113–115], as
well as in DNA synthesis control and cell cycle regulation in both normal and cancer cells [111,116,117].

















































































Figure 2. Schemes of feedforward loops (FFLs). Lines ending with an arrow indicate activation,
whereas T ending lines indicate repression. Simple straight lines indicate that the interaction can either
be activatory or repressive. (a) On the left, the general scheme of an FFL is represented. The master
regulator gene A regulates gene C both directly (left path) and indirectly (right path) through the direct
regulation of gene C. The central and right schemes synthesize all possible miRNA mediated FFLs:
the miRNA can either play the role of a master regulator or standing in the intermediate regulator
position. (b–d) Coherent miRNA mediated feedforward loops (cFFLs): regulatory paths make an
overall positive sign. In (b) and (c), the TF plays the role of the master regulator, while in (d), such a role
is assumed by the miRNA. (e,f) Incoherent miRNA mediated feed-forward loops (iFFLs): regulatory
paths make an overall negative sign. In (e), the TF acts as the master regulator by activating both
the miRNA and the target; in (f), the master regulator is the miRNA that represses both its targets.
One of the targets then represses the other one. (g–j) Experimental examples of miRNA mediated
cFFLs. (g) Two FFLs regulating the “all-or-none” expression of two groups of type 1 specific genes
in human epithelial tumour cells. Adapted from [105]. (h) FFL mediated by miR-27a/b-3p regulating
the expression of two target genes (PPARG and SCAMP3) in adipogenesis. The expression of PPARG
upregulates SCAMP3. Adipogenesis has been found to be positively regulated by PPARG (grey arrow)
and negatively regulated by PPARG (T-ended grey line). Adapted from [104]. (i) miRNA mediated
FFL that fine tunes G0/G1-S transition during the cell cycle: the miR-17 family regulates both E2F1 and
RB1, whose expression inhibits E2F1. Adapted from [117]. (j) Oncogenic transformation is regulated by
miRNA let-7 through a cFFL: NF-κB regulates IL6 directly and indirectly through let-7. A feedback is
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present between IL6 and NF-κB. Adapted from [52]. (k–m) Experimental examples of miRNA mediated
incoherent feed-forward loops (iFFLs). (k) iFFL that controls proliferative signal: the proto-oncogene
c-MYC directly controls E2F1 transcription and indirectly controls its translation through activation
of miR-17 and miR-20a. Adapted from [118] (l) miR-263a controls cell crowding in the fly retina
development, by regulating the pro-apoptotic gene head involution defective (hid) both directly
and indirectly through the RAS/MAPK pathway. Adapted from [119]. (m) The miRNA lin-4
dampens expression oscillations of its target miRNA lin-14 through an FFL where both miRNAs
are synchronously transcribed by a pulsatile source S. Adapted from [120]. (n) General scheme of
an miRNA mediated intronic self-loop.
Different biological functions can emerge [42] depending on the interactions among the nodes of
miRNA mediated FFLs, which are schematised in Figure 2a. FFLs are usually classified depending on
the overall sign of their interactions, where the overall sign is calculated by multiplying the signs of
each single path [2]. Based on this definition, the FFLs are classified as coherent (see Figure 2b–d) or
incoherent (see Figure 2e,f) if the overall sign is either positive or negative, respectively. These two types
of FFLs, as illustrated below, give rise to a wide range of features related to conferring robustness to
the regulatory network in development and decision making.
2.2.1. Coherent Feed-Forward Loops
Mutually exclusive spatial expression of miRNA and its target characterises coherent FFLs
(cFFLs) [102]. The case shown in Figure 2c, where a TF activates the target and represses the miRNA,
thus effectively reducing the miRNA mediated target repression, suggests a fail-safe control role of the
circuit, since the miRNA and target cannot be co-expressed. This has been experimentally proven in
the case where either the TF or the miRNA was the master regulator of the circuit [104] (Figure 2d).
Evidence showing the lack of co-expression of the two molecular species has been observed during the
development of Drosophila [121], as well as in mice [122] and epithelial tumours [105].
In the example of epithelial tumours, Kobayashi and colleagues found that two miRNA mediated
cFFLs regulate the expression of genes specific to one of the two phenotypes that human epithelial
tumour cells may present, called type 1 [105]. These cFFLs involve the miRNA miR-199a, a catalytic
subunit of a complex that regulates gene transcription (Brm) and the transcription factor EGR1;
see Figure 2g. One of the two cFFLs has the miRNA as the master regulator, which downregulates
type 1 specific genes both directly and indirectly through the downregulation of Brm, which in turn
activates the genes. The other cFFL has EGR1 as the master regulator targeting the same type 1 specific
genes both directly and indirectly through the activation of miR-199a. The activity of both loops leads
to a mutually exclusive expression of miRNA and both its targets, and the expression of the type 1
specific genes occurs in an “all-or-none” manner.
Interesting examples that underline the importance of miRNA mediated cFFLs in defining
spatio-temporal boundaries during differentiation have been also found in other human cells,
like neurons [103] and human fat cells [104]. In a recent work focused on the formation of new
human fat cells, the authors identified a novel cFFL involved in adipocyte differentiation [104].
The network motif is characterised by an miRNA (miR-27a/b-3p) playing the role of the master regulator
of a transcription factor (peroxisome proliferator activated receptor gamma (PPARG)) and of a second
target gene, the secretory carrier membrane protein 3 (SCAMP3). SCAMP3 is then positively regulated
by PPARG; see Figure 2h. Since the miRNA controls the expression of both target genes, it could
either prevent the excess (or lack) of target transcripts [11,123] or fine tune the ratio of the expression
of the target genes, the latter predicted through stochastic modelling by Riba and colleagues [117].
Kulyté and collaborators evidenced opposite effects of PPARG and SCAMP3 on adipogenesis and on
the functions related to adipocytes [104]. PPARG positively regulates adipogenesis, while SCAMP3
is an endogenous limiter of adipogenesis driven by PPARG. In other words, SCAMP3 negatively
regulates the process. The regulation of adipogenesis is then fine tuned by the enrolment of PPARG
and SCAMP3 within the cFFL mediated by miR-27a/b-3p. Thus, the net effect of such a loop is to tune
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the ratio between PPARG and SCAMP3, which could be relevant for maintaining a balance between
hypertrophic and hyperplastic expansion of adipose tissue in obesity.
In [117], Riba and coworkers, in support of their theoretical findings about cFFL, presented a cFFL
involving the miR-17 family as the master regulator, E2F1 as the transcription factor and RB1 as
the target gene, positively regulated by E2F1; see Figure 2i. The motif is involved in the transition
between the G0/G1 and S cell cycle phases, since E2F1 belongs to the family of genes that control such
a transition. In phase G0, E2F1 and RB1 proteins are bound in complexes in almost all cells. In such
a case, RB1 inhibits E2F1 functions and thus the cell cycle. On the contrary, in the presence of a stimulus
that promotes cell division, the binding of E2F1 and RB1 is reduced, and the free-from-binding E2F1
proteins trigger the cell cycle. Thus, for a correct functioning of the transition between the two cell
cycle phases, the relative concentration of the two genes must remain stable against fluctuations.
The authors suggested that this is guaranteed by the miRNAs within the cFFL.
Another interesting example was shown in [52], where a cFFL limits the impact of noise in an
oncogenic switch in response to an inflammatory signal [42]. The loop involves the transcription factor
NF-κB, which directly activates a mediator of the inflammatory response, the cytokine interleukin-6
(IL6), and inhibits the miRNA let-7, which in turn represses IL6; see Figure 2j. Interestingly, the loop
functions as an AND logic gate [3]: the activation of both the arms of the motif is necessary in order to
reach the level of IL6 activity that allows cellular transformation. Such transformation is also aided
by a positive feedback loop between NF-κB and IL6. The presence of let-7 prevents the noise in the
activity of NF-κB or IL6 from triggering the NF-κB/IL6 feedback loop.
The role of miRNAs in conferring stability to differentiation processes when embedded in cFFLs
has been also highlighted in [115], where the authors investigated the role of miR-7 in the differentiation
of photoreceptor cells of Drosophila. The authors showed how two interlinked cFFLs with a TF as master
regulator lead to a general expression stability. However, if the function of miR-7 is compromised, this
stability is lost, and the system can be perturbed by temperature variations.
Several theoretical works discussed the role played by cFFLs in managing fluctuations [112,117,124,125].
In [125], Duk and collaborators found that cFFLs do not show absolute adaptation in response to external
signals, i.e., the target expression level does not return to its baseline level after a transient external signal,
neither if the signal is small. The ability to adapt to different environmental conditions is an important feature
for living organisms, especially in noisy environments. The absence of adaptability suggests that cFFLs may
be present only in those systems where a substantial change of the target expression, even if induced by
small changes in the external condition, is not deleterious.
2.2.2. Incoherent Feed-Forward Loops
miRNAs may play a dual role in the presence of noise: on the one hand, they may
generate and take advantage of fluctuations in order to perform defined tasks or to drive
differentiation [44,119,126,127]; on the other hand, they can confer phenotypic robustness to gene
expression by suppressing this variability [88,122,123,128–130]. In this framework, miRNA mediated
circuits have been modelled as incoherent FFLs (iFFLs), as shown in Figure 2e,f. Stochastic modelling
and numerical simulations were proven to be a powerful instrument to establish the role of miRNA in
conferring robustness to these circuits by buffering gene expression fluctuations [6,48,128,131–134].
Furthermore, while cFFLs promote the avoidance of the spatial co-expression of miRNA and their
targets, iFFLs can promote the temporal phase shift between molecular species. Let us consider an
iFFL where a TF acting as the master regulator induces the expression of both the miRNA and the
target (Figure 2e). Even if activated by the same TF as its own target, miRNA expression appears to be
delayed as a consequence of its own biogenesis [11,102]. Yet, once expressed, the miRNA inhibits the
target, therefore inducing the temporal phase shift mentioned above.
An example of an miRNA mediated iFFL with a TF as the master regulator was described in the
work of O’Donnell and colleagues [118]. The circuit involves the proto-oncogene c-MYC that encodes
a TF responsible for the regulation of cell growth, proliferation and apoptosis. The authors found
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that c-MYC directly controls the transcription of E2F1 and indirectly limits E2F1 translation through
the activation of the expression of a cluster of miRNAs; see Figure 2k. In [130], He and collaborators
investigated an iFFL similar to that of O’Donnell et al. involving again MYC as the master regulator,
the miR-17-92 cluster and E2F (E2F1 is a member of E2F family), and they showed that this type of
loop effectively contributes to reducing gene expression fluctuations and therefore conferring to the
miRNA the role of fine tuner of gene expression.
Analogously, Hilgers and collaborators [119] showed that the miRNAs miR-263a/b prevent
programmed cell death of mechanosensory cells during fly retina development and confer robustness
to the sensory organ specification (a role already proposed in [115] for the miRNA miR-7 involved both
in a cFFL and an iFFL). A scheme of this iFFL is shown in Figure 2l: miR-263a controls the expression
of the pro-apoptotic gene head involution defective (hid) directly and indirectly through the RAS/MAPK
pathway (composed in this case of Ras85D and ERK). With the sole direct path, the effect of the miRNA
would be that of downregulating the expression of hid and thus its activity. However, this is mitigated
by the indirect path through which miR-263a inhibits a hid repressor. The activity of the miRNA is thus
to ensure robustness during apoptotic tissue pruning.
On the theoretical side, the work in [48] deeply studied the role of the iFFL in buffering
gene expression fluctuations and compared it to other topologies by stochastic modelling and
numerical simulations. Further works followed the one by Osella and colleagues [112,124,125,135,136].
More specifically, Duk and collaborators [124] confirmed the ability of the miRNA mediated iFFL to
respond to a sudden change in the quantity of TF regulator with only a small deviation from the steady
state. This allows highlighting the outstanding role of these regulatory motifs in those systems where
changes in the target protein may cause serious consequences. However, this noise buffering property
is evident only if the strength of the coupling between miRNA and target is tuned in a relatively small
functional range. Outside this range, the circuit tends to either amplify fluctuations (strong coupling)
or to produce a Poissonian statistics for the output variable (weak coupling) [137].
An important property of miRNA mediated iFFLs derived through mathematical
modelling [125,138] is their ability to adapt to transient signals, as purely transcriptional iFFLs [139].
Bleris and collaborators [140] studied the adaptability to changes in DNA template abundance through
the development of synthetic transcriptional and post-transcriptional iFFLs in human embryonic
kidney cells. They found that in all cases, the gene product levels adapted to changes. In addition
to this, the post-transcriptional form showed a better adaptive behaviour, higher absolute levels of
expression and lower levels of intrinsic fluctuations when compared to the purely transcriptional case.
These results, in agreement with theoretical expectations [112,124,125], support the endogenous role
of this motif in gene dosage compensation. Thus, the implementation of miRNA mediated iFFLs in
synthetic networks would improve their robustness. Yet, the ability of the miRNA mediated iFFL to
control protein noise can be altered in the presence of bursting inputs, as shown through stochastic
modelling and numerical simulations in [137].
Similarly to what has been discussed regarding FLs, iFFLs can produce oscillatory outcomes under
peculiar conditions. An interesting example, carried out by Kim and collaborators [120] and reviewed
in [141], consists of an iFFL involved in the development of Caenorhabditis elegans. The timing of its
developmental stages is stressed by oscillatory expression patterns. It is known that lin-4 oscillates
according to these stages, whereas lin-14 displays a seemingly constant negative gradient throughout
development of the wild-type worm. By investigating the relationship between lin-4 and lin-14, the
authors found out that these two miRNAs are connected by an iFFL, as shown in Figures 2m and 3h.
By knocking down lin-4 transcription, that is silencing the inhibitory arm of the iFFL, they showed
that lin-14 undergoes pulsatile dynamics as well. It is thus suggested that the pulsatile expression of
lin-4 dampens the expression oscillations of its target lin-14, thereby ensuring its temporal gradient.
Temporal expression of lin-14 in wild-type and in the lin-4 lacking mutant is qualitatively represented
in Figure 3i. Moreover, the dampening is shown to be optimal if lin-4 and lin-14 are transcribed together
with in-phase pulses [120]. This could more generally represent a mechanism that serves to insulate
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key developmental players from upstream oscillatory or noisy signals. Several further examples can
be brought forward to show that iFFLs are well suited to act as triggers for oscillatory systems and
underline their importance in preventing the propagation of fluctuation in gene expression that might
damage a developing organism [42,115].
iFFLs mediated by miRNAs have also been shown to detect gene expression fold changes [11,142].
Fold change detection is a feature related to Weber’s law: the response of a system depends on
relative rather than absolute changes in the input signal with respect to a basal level. Mathematical
modelling [143] showed that iFFLs display such a property for a wide range of biochemical parameters.
Having a fold detection mechanism may allow identical responses to external signals despite the
cell-to-cell variability in the basal levels of master TFs.
2.2.3. Intronic microRNA Mediated Self-Loops
As mentioned above, the functions of many intronic miRNA appear to be correlated with those
of the genes encoding the miRNAs themselves [144]. Using measures based on both annotation and
experimental data, Lutter et al. suggested that many miRNAs link host and target gene activity in an
either synergistic or antagonistic manner [145]. Here, we will focus on a minimal interaction circuit
that sees intronic miRNAs as direct repressors of their host gene, that is the intronic miRNA mediated
self-loop (iMSL), shown in Figure 2n. The iMSLs, which can be viewed as a compact version of an iFFL,
can be represented by a master TF that regulates a single genomic locus encoding both the host gene
and the miRNA, with the host gene in turn targeted by the miRNA [13]. Bioinformatic studies have
found that iMSLs are significantly enriched in the human regulatory network [146], with approximately
20% of intronic miRNAs predicted to target their host gene [144]. This suggests that iMSLs can perform
specific biological functions, potentially not achievable by other circuit topologies.
The question of the reason why intronic miRNA mediated gene autoregulation would be more
suitable to fulfil certain tasks has been addressed both theoretically and experimentally [13,135,147].
Bosia and co-workers carried out a controlled mathematical comparison between the iMSL and other
circuit topologies in order to highlight the iMSL’s specificities in implementing particular functions.
The results indicated that the iMSL can accelerate the synthesis of the host gene protein in response to
an input signal and can delay its knockdown when the input signal drops. As other circuit topologies,
it can efficiently buffer fluctuations of the upstream signal. In addition, the iMSL is able to implement
complex functions such as a host gene expression obeying Weber’s law, that is the response only
depends on the input’s fold change and not on the input’s absolute value [13].
Strovas and colleagues [147] engineered a synthetic iMSL circuit composed of a doxycycline
inducible fluorescent reporter self-regulated by its intronic miRNA miR-124 (Figure 3d). As a control,
the authors engineered an analogous loop lacking the inhibitory arm (open-loop, Figure 3c).
By integrating these circuit into the cells’ genome and then measuring the fluorescent reporter
amounts, they found that the iMSL showed adaptation (i.e., a transient protein expression pulse
before returning to a lower steady-state level in response to a step-like increase in transcription rate),
while the open-loop did not (Figure 3e). Moreover, the steady-state protein levels for the iMSL were
independent of the size of the stimulus, thereby buffering protein production against changes in
transcription (Figure 3f) and reducing cell-to-cell expression variability (Figure 3g). Yet, to this concern,
a newly published study highlighted the dependence of the iMSL’s noise buffering efficiency on the
time scale of fluctuations [135].
A series of endogenous iMSLs have also been experimentally uncovered in small scale
studies [148–154]. Chuang et al. [155] found miR-93-3p and MCM7 to be oppositely expressed in
leiomyomas. Since the MCM7 gene encodes a protein that plays an important role in cell cycle,
miR-93-3p may regulate replication and cell cycle progression through an iMSL. Another iMSL
involving miR-26b was found to control neuronal differentiation by post-transcriptional repression of
its host gene, CTDSP2 [149]. However, the experimental validations of this kind of circuit are still in
their infancy, as only a few examples of iMSLs have been confirmed to date [156].
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Figure 3. Examples of different experimental circuits showing properties theoretically predicted.
(a) Example of the double negative feedback loop (DNFL) that displays bistability described in
Fang et al. [100]. The circuit involves SOX2 and miR-145. (b) Bistable output of the DNFL. SOX2
temporal expression is depicted in blue and miR-145 temporal expression in red. The relative activation
strengths determine whether the system settles in the high-miR-145 state or in the high-SOX2
state. Panels (c–g) report a schema of the results obtained by Strovas and colleagues [147] for
an intronic miRNA mediated self-loop (iMSL). (c) The engineered open-loop. (d) The engineered
iMSL. (e) Unlike the open-loop, the iMSL displays output adaptation. When a sudden input
(left panel) is given to the system, the output fluorescence of the open-loop responds with an increasing
trend (central panel), while the iMSL produces a pulse before reaching a lower steady-state level
(right panel). (f) In the open-loop case (central panel), output levels depend on input signal intensities
(left panel). On the contrary, the adaptive output level of the iMSL does not depend on the input size,
and the iMSL buffers gene expression (right panel). (g) The iMSL displays noise reduction: for a given
mean fluorescence value, the coefficient of variation (CV) is significantly lower in the iMSL case (in red)
than in the open-loop (in blue). (h) The iFFL addressed by Kim and co-workers [120]. Lin-4 and lin-14
miRNAs are both transcribed by an upstream TF and lin-4 post-transcriptionally targets lin-14. (i) Lin-14
temporal expression in wild-type C. elegans (blue) and in mutant with lin-4 transcription knock-out
(red). Lin-14 oscillation are dampened by lin-4 pulsatile expression (adapted from [120]).
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Summarising, the iMSL appears in general to be another useful way of maintaining cellular
homoeostasis and conferring robustness to gene expression, coherently with the emerging idea of
miRNAs as fine tuners of biological processes.
3. MicroRNAs in Synthetic Circuits and Therapeutic Perspectives
In the previous sections, we summarised and discussed the main properties of miRNA mediated
gene regulatory networks, with particular attention to network motifs. Up to this point, the properties
of endogenous circuits have been discussed. However, the ability of engineering synthetic regulatory
networks, as well as integrating them in cells through plasmids or viral vectors gives the unique
opportunity of investigating complex networks’ behaviours under highly controlled conditions [157].
Besides representing a powerful experimental setup to test the predictability of theoretical results,
these techniques, globally referred to as synthetic biology, give a chance to convey the first milestone
results for therapeutic purposes.
Synthetic biology is based on a strongly interdisciplinary approach called cybergenetics [158],
where the concepts of cybernetics are integrated with control theory, biological engineering and
mathematical modelling in order to design synthetic circuits able to tune gene expression and thereby
control cell functions [158,159]. The design of these circuitries able to sense multiple biological inputs,
process complex information and finally give physiologically active responses is a long-standing
challenge [160]. In particular, the reprogramming of genomic activities in mammalian cells could
provide therapeutic strategies for a variety of diseases [161]. For instance, regulatory networks built to
detect and selectively react to certain cellular conditions could exert anti-cancer actions [162].
A vast amount of studies have focused on the design of regulatory motifs controlled by
transcriptional signals [160]. After purely TF mediated synthetic circuits, recent proposals rely on RNA
interference (RNAi) logic; that is, the circuit’s outcome depends on the interference of some RNA
molecule with protein production. Specifically, engineered miRNAs are now widely used as circuit
modules in order to exploit their well discussed regulatory features [163]. Generally, networks based
on RNAi are constructed by coupling the binding of an input ligand to an RNA aptamer with the
biogenesis of the RNAi [164]. In fact, many studies used a ligand that binds to the aptamer and thus
causes conformational changes that inhibit miRNA biogenesis [165], thus affecting the production of
an miRNA targeted protein [165].
Leisner et al. [160] proposed a general method for implementing transcriptional regulatory
programs with RNAi circuits in mammalian cells by transfection. Their model has multiple TF inputs
and a fluorescent protein output, and it is composed of different modules. In one module, each TF
regulates a sensory miRNA gene. The mature miRNA converges on its mRNA target, which encodes an
output protein tagged with a fluorescent dye that enables its quantification. By calibrating the features
of constitutive regulator TF expressing vectors, miRNA expressing vectors and reporter plasmids
encoding targets, the circuit’s response can be tuned. This approach is presented as a basic starting
point for more complex synthetic circuits that make use of RNAs [160].
An example of great interest for the purposes of this review is the work of Lillacci and
collaborators [158], who reported new controllers of gene expression in mammalian cells containing
post-transcriptional feedback and feed-forward regulation mediated by miRNAs. The authors designed
and transfected in mammalian cells four controllers based on RNAi logic. The four implemented
circuits were: (i) an open-loop (OL), (ii) a feedback loop (FL), (iii) an incoherent feed-forward loop
(iFFL) and (iv) an hybrid of feedback and incoherent feed-forward loops (HYB). All of these circuits
were implemented using plasmids with the same genes, and the only difference among the four was
due to the regulatory relationships among them. The plasmids were composed by (i) a constitutively
expressed yellow fluorescent protein (mCitrine) that represents a proxy for the amount of plasmid
uptaken by the cell, (ii) a blue fluorescent synthetic controller (tetracycline-controller transactivator
tTA-Advanced, called TA, fused to Cerulean) that induces the expression of both; a (iii) red-fluorescence
protein of interest (DsRed) and (iv) an intronically encoded miRNA (miR-FF4). In order to implement
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different circuitry logics, the 3′-UTR regions of both TA and DsRed were engineered to contain or
not binding sites for miR-FF4. The activity of TA over its downstream gene was externally tuned
through doxycycline (DOX), which inhibits TA activity. Quantification of the expression levels has
been performed through flow cytometry. Figure 4a reports the four loops.
Examples of synthetic circuits
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Figure 4. Examples of synthetic circuits. (a) Schemes of the four miRNA based controllers
engineered in Lillacci et al. [158]. All the implemented circuits involve the same upstream regulator
(tetracycline-controller transactivator TA), which targets a gene with intronic miRNA. In the open-loop
(OL), the miRNA cannot bind the target. In the feedback loop (FL), TA is provided with miRNA
binding sites; thus, a feedback is formed between the two species. In the incoherent feed-forward loop
(iFFL), the gene is targeted by its intronic miRNA, thus forming an intronic miRNA mediated self-loop.
In the hybrid loop (HYB), both the upstream regulator TA and the gene are targeted by the miRNA;
thus, a hybrid-type loop is formed. (b) Scheme of the OFF switch implemented by Bloom et al. [165].
The ligand, an input protein P, inhibits the ribozyme (Rb), thereby preventing its cleavage action on
the miRNA. Thus, miRNA biogenesis occurs, and the target gene G is repressed. In the following
phase, the OFF switch is shaped in such a way that the target coincides with the input protein
itself, thus forming a controlled feedback loop that exhibits input level adaptation. (c) The identified
miRNAs (two HeLa-high and three HeLa-low markers) target the same apoptotic gene, hBax. Adapted
from [162].
The open-loop represents the standard inducible gene expression system and is engineered
without miR-FF4 binding sites: TA therefore induces the expression of both the miRNA and the
target. In the feedback loop instead, TA is provided with miRNA binding sites, therefore defining
a feedback loop between the miRNA and its activator. The feed-forward loop is instead implemented
via an intronic miRNA self-loop: miR-FF4 binding sites are on the 3′-UTR region of the DsRed;
thus, both miRNA and its target are activated, and the miRNA represses the target. Finally, the hybrid
loop (HYB) is the union of the last two loops: miRNA binding sites are present on both TA and DsRed.
Through such controllers, the main properties of the different loops discussed in the previous
sections have been recovered. In particular, the authors showed that (i) the negative FL was able to
confer robustness to TA dosage variability and improved output protein yield, (ii) the iFFL could tune
the output expression and confer robustness to variability due to plasmid uptaking and (iii) the hybrid
circuit showed ability in tuning the output, conferring robustness to plasmid uptaking variability,
and showed adaptation to gene dosage. Moreover, the authors integrated such circuits in biologically
interesting systems in order to improve their performances. For instance, the transfection of the FL into
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Chinese hamster ovary cells, usually implied in protein manufacturing, increases product levels by
eliminating the burden effect induced by TA. Burdening represents indeed one of the main drawbacks
in bioproduction affecting cell physiology: several bioengineering efforts have been made in order
to limit this effect [166,167]. Moreover, the advantages of iFFL and HYB circuits have been observed
by their transient transfection in human induced pluripotent stem cells. In the control situation, high
levels of transgene expression were toxic to the cell line, and the presence of either iFFL or HYB
allowed mitigating the toxic effect by regulating gene expression.
Inspired by the property of some miRNA mediated network motifs of preserving intracellular
protein levels, cellular homoeostasis maintaining RNAi networks have been engineered [165].
A study by Bleris et al. [140] showed that the iFFL implements gene expression adaptation in
mammalian cells. Specifically, the authors synthesised and tested FFLs based either on transcriptional
or post-transcriptional regulation and observed that the output recovered adaptive levels in
response to template abundance variation. Another interesting homoeostasis controlling system
has been developed by Bloom and colleagues [165]. It consisted of a synthetic FL that combines
a ligand responsive ribozyme switch and synthetic miRNA regulators. While most of RNAi devices
function as ON-switches, that is the output protein’s expression increases with ligand concentration,
they developed a circuit that conversely increases silencing of the product by an miRNA in the
presence of a ligand, thereby realising an RNAi based OFF-switch. This was possible by using a
ribozyme (Rb) whose presence ensures pri-miRNA formation and consequently silences the target
gene. This OFF-switch was then used to target the ligand protein itself in an miRNA-controlled
negative feedback that maintains constant protein levels in response to increases in the transcription
rate [165], as shown in Figure 4b. This type of circuit can be a powerful way of stabilising cellular
phenotypes, thus having useful therapeutic implications [165].
Of course, the well known simple network motifs can be combined in order to obtain better
performing synthetic circuits [168]. Reeves and co-workers analysed the effects of combining different
synthetic motifs on output adaptation and robustness: they combined an FFL with a negative feedback
and showed that this network showed more robust dynamical adaptation properties than simple FL or
FFL systems [168].
3.1. MicroRNAs as Classifiers
A network’s ability to implement gene expression conditions can also be used for recognising
cancer cells and triggering their apoptosis [164]. This idea lies behind the popular recent field of
cell classifiers in synthetic biology [157,169]. A classifier is a regulatory network that detects sensory
information from multiple molecular markers to determine if a cell is in a specific state and to produce
consequently a biologically active protein output [162]. A major challenge for cancer therapy is to
eliminate cancer cells without damaging the surrounding healthy ones [161]. In this view, cell classifiers
appear to be great candidates to sense pathological cell conditions and to generate targeted therapeutic
responses [161].
MiRNA responsive circuits are particularly useful for these purposes, as miRNA expression can
be seen as a signature of the cell’s condition and identity [159]. In this view, Xie and co-workers built
a synthetic miRNA mediated circuit capable of distinguishing cervical cancer cells (HeLa cells) from
other cell types. This circuit senses the expression intensities of a customisable series of endogenous
miRNAs and activates a cellular response if these intensities match a pre-established profile [162].
More precisely, it can sense the expression of six different miRNAs and compare it to a previously
constructed reference profile that is supposed to identify HeLa cells [162]. Depending on the output,
it can then trigger the expression of an apoptosis inducing protein, hBax. A few miRNAs were
identified as HeLa-low or HeLa-high markers. Then, the circuit’s response function was modelled as
a combination of logic AND/AND NOT operations on all miRNA inputs. This computation can be
built in a network by choosing a homogeneous pool of miRNA targets (hBax expressing gene, Figure 4c)
and implementing two feedforward loops with a threshold-like output expression. The constructed
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circuit performed as desired, the outcome being significantly higher in HeLa cells compared with the
other cell lines used. Moreover, it selectively killed HeLa cells with respect to other cells [161].
Besides the usefulness of miRNA sensing in order to select apoptotic cells, Hirosawa et al.
showed that endogenous miRNA profiles can be used by a regulatory switch for controlling genome
editing [170]. A synthetic network can trigger effective biological programs by detecting complex
intracellular signals. Nevertheless, therapeutic applications require the overcoming of challenges
such as efficient in vivo DNA delivery to cells [162]. Moreover, as DNA delivery can lead to random
genomic integration, RNA delivered circuits are preferable for medical purposes in terms of safety [159].
A recently published work [159] used an all-RNA system that provides an alternative to DNA delivery.
A multiple miRNA sensing circuit for logic computation in mammalian cells was constructed using
an RNA-only delivery approach. This kind of RNA based logic circuit with RNA binding proteins tunes
the output’s production with the aim of selectively controlling cell death pathways. Five logic gates
(AND, OR, NAND, NOR, XOR) were created and validated by measuring the output’s net fold-change,
and all circuits displayed statistically significant performance [159]. Specifically, a two-input AND
circuit involving an apoptotic gene led to precise elimination of target cells.
More generally, circuit topology can be optimally shaped in order to generate the best candidate
circuits for precise cell targeting and avoid the extensive use of empirical trials. This issue has been
addressed by Mohammadi et al. in a recent work [171] by using again miRNA expression datasets as
phenotype markers. In this study, a computational method was presented for designing experimentally
feasible miRNA mediated circuits that can distinguish cells according to various actual classification
problems [171]. A unique circuit specification comprises the set of inputs, the network topology,
and a set of biochemical parameters such as rate constants and initial conditions that determine its
dynamics [171]. Obviously, optimisation is burdened by the combinatorial explosion of the number
of possible circuits. A two step approach can be used to solve this issue: first, an optimised set of
biochemical parameters is derived over a set of different topologies; second, the circuit topology is
optimised for each task using the globally inferred parameters obtained in the first step [171]. In sum,
this work provides a method that identifies a single circuit with optimal classification performance,
that is producing the highest output levels in target cells with respect to all other cells [171].
Yet, the optimisation of single circuit classifiers often suggests the design of highly complex
structures that are difficult to build in the real world [157]. A newly published study by Nowicka
and colleagues made use of the so-called distributed classifiers (DC), that is sets of small and simple
network motifs that function in an integrated manner and produce a collective response according to
a threshold function [157]. Specifically, an initial set of simple networks is trained using a machine
learning algorithm, and as a consequence, low-performance circuits are withdrawn. By using real
cancer data, it was shown that such a set of simple classifiers performs better in terms of classification
and is more robust with respect to a single complex circuit, as the integration of individual outputs
compensates for single circuit errors. This suggests that DCs may also manage noise in the input data
better than single network classifiers [157].
More recently, the achievements of synthetic circuits have gone beyond the simple cell type
recognition thanks to a new work by Endo and colleagues [172], which showed that their mRNA based
circuits are not only capable of discriminating human cells, but they can also track their change when
they differentiate. Thus, their work opened the possibility to make decisions also based on dynamical
information on the intracellular state.
Cell dynamics tracking of course opens questions about how to reprogram differentiated cells to
pluripotent cells [173] or how to control stem cell differentiation precisely [174]. Yet, one of the greatest
challenges for clinical applications is that of ensuring that engineered cells do not present side effects
to humans [161]. To lower this risk, host cells should be replaced by primary cells or stem cells isolated
directly from the patient. Thus, induced pluripotent stem cells may pave the way to personalised
medicine by allowing the generation of patient specific cells and tissues that do not have to be derived
from embryos [173].
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As discussed, miRNA mediated synthetic networks open a wide range of useful biomedical
possibilities. Future perspectives of miRNA mediated synthetic motifs involve the development of
circuits with high biocomputing capacity, able to integrate a large number of diverse inputs in order to
provide always more sophisticated biological responses.
4. Conclusions
The network motifs discussed so far were generally considered as single blocks composed by
a small number of interacting units. Despite their simplicity, we showed how they are able to give
rise to complex biological functions linked to noise processing. However, by enlarging the picture,
they represent single building blocks of the bigger and more complex network that regulates gene
expression in eukaryotes.
As already mentioned in some of the examples reported in the previous sections [52,115,130],
the regulatory output and thus the role of the single players is often the result of the interconnection
of some of the elementary circuits, like the combination of a feed-forward loop with a feedback
loop [52,130]. For instance, in [130], an interplay between miRNA mediated feedback and feed-forward
loops that share some of their components may provide the miRNA with the dual role of oncogene
and tumour suppressor. In addition to this, a specific biological feature (see for example the ability of
suppressing noise) may be achieved through different pathways, suggesting, from a mathematical
point of view, the non-uniqueness of the solution [11,112].
The NF-κB regulatory network displays a striking example of this behaviour. As discussed, NF-κB
is involved in a series of interconnected miRNA mediated loops that regulate inflammatory response.
However, the regulatory relationships between miRNAs and NF-κB go well beyond the few loops
shown so far. Markopoulos et al. [175] reviewed the connections of NF-κB with several miRNAs that
modulate inflammation in cancer and discussed the role of each of these connections. For instance,
an NF-κB/miR-155 network appears to calibrate the intensity and duration of inflammation, whereas
the NF-κB/miR-21 loop displays an amplification behaviour that can lead from inflammation to
cancer [175]. Furthermore, Rokavec and colleagues reviewed the roles of different NF-κB involving
circuits in linking inflammatory conditions to cancer initiation and progression [176]. Since we cannot
entirely report the described NF-κB network, an idea of its importance and ubiquity can be caught
from the impressive number of NF-κB/miRNA interactions: genomic data provide a list of 162
miRNAs regulating NF-κB and, vice versa, 40 miRNAs targeted by NF-κB [175]. In sum, it is likely
that the net outcome of NF-κB’s dense network can either favour cancer development or limit it.
Moreover, some miRNAs that are regulated by NF-κB in turn regulate the already mentioned p53
involved in breast cancer development and vice versa [177]. Thus, the NF-κB and the p53 interactomes
are connected as well, and together, they may determine the neoplastic transformation of a cell or
oppositely tumour suppression [177].
By looking more closely at the p53 interactions with miRNAs, again, a number of p53 regulated
and p53 regulating miRNAs have been identified. These miRNAs appear to be involved in cell
cycle regulation, stemness regulation and cell survival, amongst others. Focusing on their cancer
related roles, a part of these miRNAs acts as tumour suppressors, while some of them play oncogenic
roles in the intricate p53/miRNA network [178]. An outstanding example among the p53 related
miRNAs is represented by the miR-34 family members, which have been found as the prevailing
p53 induced miRNAs, as reviewed in [179]. Coherently with the well known relation of p53 with
several types of tumours, this miRNA family has been implicated in diverse cancer related functions,
such as proliferation, apoptosis, EMT, migration, and metastasis, as summarized by Rokavec and
colleagues [179] and Yamakuchi et al. [180].
Furthermore, the epithelial-to-mesenchymal transition has been shown to be also connected
to NF-κB. Indeed, the inflammatory signals that activate NF-κB also feed back on EMT inducing
TFs, such as the already mentioned SNAIL and ZEB. For a review, see [181]. The NF-κB and p53
interactomes only give an insight into the importance of considering the ensemble of simple interactions
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as a whole. In sum, the functions of single motifs must be taken collectively into account in order to
predict global biological responses, especially for therapeutic aims.
By zooming out from the simple network motifs, these may be part of a bigger and more complex
regulatory network composed by the miRNAs and all their target genes. Indeed, the miRNA–target
interaction has a combinatorial nature: one miRNA can regulate several targets, and these in turn can
be regulated by several miRNAs. Such a feature, coupled with the molecular sequestration mechanism
of miRNA-target binding, may induce cross-talks among the targets that compete to bind to the
same miRNA pool, giving rise to a layer of post-transcriptional cross-regulation recently called the
ceRNA (competing endogenous RNA) effect [22]. The number of binding sites in ceRNA candidates is
inversely related to the effective concentration of free targeting miRNAs, making the shared miRNA
binding sites cross-talk hubs of gene interactions. In light of this, the deletion of shared miRNAs by
ceRNAs and the competition for binding represents an indirect mechanism for cross-regulation and
interaction among RNA species [11].
Some examples in the literature show functional effects of ceRNAs in contexts like cancer [19,26],
cell differentiation [182] and self-renewal of embryonic stem cells [183]. However, up to now,
the broader characterisation of ceRNA properties has been performed under a theoretical point
of view both through stochastic modelling and in silico simulations [20,21,45,184,185], as reviewed
in [186]. Quantitative experiments that allow testing theoretical predictions are much more recent
and still limited, and the best way to address such issues experimentally seems the use of synthetic
biology. The study of engineered genetic circuits [187], in particular through the use of bidirectional
reporters [18,188,189], allows investigating such complex regulation under controlled conditions in
an isolated biological setting. A similar characterisation in those systems with evidence of functional
ceRNAs [26,182,183] would be interesting, but it is still lacking.
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